Stem Cell Therapy for Pets - Guiness Before After Amazing before and after footage of Guiness, an 11 year old dog who received stem cell therapy for his arthritis and got an unexpected side benefit. For more... By: NewmanVets … Continue reading →

Stem Cell Therapy for Pets - Sammy Before After Amazing before and after footage of Sammy, a yellow lab who received stem cell therapy for his arthritic joints. For more information about stem cell therapy... By: NewmanVets … Continue reading →

GM OFFLINE TRAINING. By: Guillermo Mata … Continue reading →

Stem Cell Therapy Cures Paralyzed Vet By: TheVideOHM … Continue reading →

Jack Loo | March 25, 2013 The A*STAR spin-off says its methods can make cell transplantation safer. Singaporean startup VeriStem Technologies was ranked as one of the recipients in the Biospectrum Emerging Companies of the Year Award 2013 for its tools that enable the development and manufacture of safe stem cell therapies. Veristem, a spin-off from Singapore government agency A*STAR's Bioprocessing Technology Institute (BTI), was founded in 2009 by its president Alan Moore and chief operating officer Keith Wang, using core technologies that were developed by a team at BTI led by Dr Miranda Yap, Dr Andre Choo, and Dr Steve Oh. The Award was established by trade publication Biospectrum to recognise startups from biotechnology, medical technology and pharmaceutical sectors across the Asia Pacific region which have developed innovative technologies with the potential to bring out revolutionary changes in the healthcare industry. Dr Andre Choo, lead scientist at BTI who worked on the antibody technology, added: "It is an honour for us to be part of this award with VeriStem Technologies. It affirms our belief that the technology can be applied to kill residual stem cells thus eliminating the risk of teratoma formation, making cell transplantation safer". Having the ability … Continue reading →

DUBLIN, March 25, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Complete 2012-13 Induced Pluripotent Stem Cell Industry Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Stem cell research and experimentation has been in process for well over five decades. Stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being unspecialized with the ability to differentiate into specialized cell types. The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain on the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community. Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use. … Continue reading →

10 Talks in 10 Minutes Through Dance: The Dance Team at TEDxWindyCity Words can sometimes fail us when we try to express complex ideas, so why not use our bodies as well? The Dance Team attempts to embody all 10 of the TEDxWind... By: TEDxTalks … Continue reading →

Every bit of it: Cynthia Liem at TEDxDelftSalon Conventionally, people would associate music with subjectivity, expressivity and emotions -- properties which sharply contrast with the image of rigid object... By: TEDxTalks … Continue reading →